• Call: +44-2038074155  |  Mail: Sales@brandessenceresearch.com  | | | | |

Insomnia Market 2020 By Product Type analysis (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis), By Application Type Analysis (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Store) Forecast to 2025

  • Report ID: BMRC 75 | Number of pages: 200 | Published Date: Dec 2019

    Published | Category: Chemical And Materials | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Insomnia Market 2020 By Product Type analysis (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis), By Application Type Analysis (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Store) Forecast to 2025 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

"Global Insomnia Market is valued around USD 4494.51 Million in 2018 and expected to reach USD 6091.87 Million by 2025 with the CAGR of 4.44% over the forecast period."

Increasing demand for sleep Aids and therapy’s, growing demand of OTC sleep aids and stressful life with unsatisfactory sleep, increased workloads and shift works are some factors driving the growth of the market.

Scope of the Global Insomnia Market Report:

Insomnia may be a common disorder which will make it hard to nod off, hard to remain asleep, or cause you to awaken too early and not be ready to revisit to sleep. You’ll still feel tired once you awaken. Insomnia can give harmful effect not only your energy level and mood but also your health, work performance and quality of life.

How much sleep is enough varies from person to person, but most adults need seven to eight hours an evening. At some point, many adults experience short-term (acute) insomnia, which lasts for days or weeks, (for example, when you can't fall asleep the night before an exam or after receiving stressful or bad news). It’s always the results of stress or a traumatic event. But some people have long-term (chronic insomnia), which is disrupted sleep that occurs at least three nights per week and lasts at least three months. Chronic insomnia disorders can have many causes. Changes within the environment, harmful sleep habits, shift work, other clinical disorders, and certain medications could lead on to a long-term pattern of unsatisfactory sleep. People with chronic insomnia may enjoy some sort of treatment to assist them revisit to healthy sleep patterns. Chronic insomnia are often co morbid, meaning it's linked to a different medical or psychiatric issue, although sometimes it's difficult to know this cause and effect relationship.

People with insomnia tend to possess difficulty falling asleep (onset), staying asleep (maintenance), and/or they awaken too early within the morning. Insomnia can include behavioral, psychological, medical components or some combination thereof for treatment.

Insomnia Market is segmented on the basis of Product Type, Therapy and region & country level. On the basis of product type, the market is segmented into Prescription Sleep Aids, OTC Sleep Aids and Others. On the basis of Therapy, the market is segmented into Non-pharmacological Therapy and Pharmacological Therapy.

The regions covered in this Insomnia Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Insomniais sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Insomnia Companies:

  • Merck & Co. Inc.
  • Sanofi, Pfizer Inc.
  • Takeda Pharmaceutical Company Ltd
  • Purdue Pharmaceuticals L.P.
  • Eisai, Co. Ltd.
  • Meda Consumer Healthcare Inc.
  • Pernix Therapeutics
  • Vanda Pharmaceuticals
  • ECR Pharmaceuticals

Global Insomnia Market Dynamics-       

Increasing numbers of insomnia patients and prevalence of OTC drugs are the main factors of this market as per consumer reports survey of 1,767 U.S. adults; nearly one-third of individuals who complained of sleep problems a minimum of once per week said that they had used an over-the-counter or prescription sleep drug within the previous year. Around 40% of individuals who take sleep aids use the drugs in potentially harmful ways—by, for instance, taking them frequently or longer than recommended, or combining them with other medications or alcohol. 80% people had sleeping problems once in a week. 31% people who had sleep problems once in a week used OTC or Rx drugs.

High cost of treatment like; Insomnia is costing the average U.S. worker 11.3 days, or USD 2,280 in lost productivity every year, Sleeping pills can cost from USD 17 to USD 60 a week. Some newer drugs may cost even more.

Sleeping pills are one among the most-prescribed drugs within the US. This is partly because many patients ask for them. Also, many doctors prescribe sleeping pills instead of trying other treatments first and Technological advancement, increasing numbers of hospitals, diagnostic centers, online treatments are some factors which could be the opportunity for the market.

North America dominate the Insomnia Market

North America is dominating the market of insomnia as per US National Library of drugs , Insomnia is costing the typical U.S. worker 11.3 days, or USD 2,280 in lost productivity once a year and as a nation, the whole cost is 252.7 days and USD 63.2 billion. Europe is leading the market after North America Europe is that the market during which the entire annual cost of insomnia within the province of Quebec was estimated at USD 6.6 billion (Cdn$). the typical annual per-person costs was USD 5,010 for people with insomnia syndrome, USD 1,431 for people presenting with symptoms, and USD 421 permanently sleepers. thanks to its rising population Asia Pacific is growing marketplace for Insomnia Market and also lower hospital treatment cost compare to other regions.

Key Benefits for Global Insomnia Market Reports –

Global market report covers in depth historical and forecast analysis.

Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global market report helps to identify opportunities in market place.

Global market report covers extensive analysis of emerging trends and competitive landscape.

Global Insomnia Market Segmentation –

By Product Type analysis: Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis

By Application Type Analysis - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Store

By Regional & Country Analysis

 North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa


Frequently Asked Questions (FAQ) :
Merck & Co. Inc., Sanofi, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, ECR Pharmaceuticals and Others
"Global Insomnia Market is valued around USD 4494.51 Million in 2018 and expected to reach USD 6091.87 Million by 2025 with the CAGR of 4.44% over the forecast period."



Interested in this report?

Insomnia Market | Statistics and Research Analysis 2025 and Analysis 2019-2025

report cover

Insomnia Market 2020 By Product Type analysis (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis), By Application Type Analysis (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Store) Forecast to 2025

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.

    Pricing



+44-1173181773
vishal@brandessenceresearch.com


Looking for Regional Reports?